To include your compound in the COVID-19 Resource Center, submit it here.

Cancer

INDICATION: Neurofibromatosis

Patient sample and mouse studies suggest c-MET inhibitors could help treat neurofibromatosis type II. In neural tissue from patients,

Read the full 202 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE